Studies Report that the New Use of PET Scan Radiotracer May Help Identify Early Signs of MS Progression
Multiple Sclerosis (MS) is a disease that damages the
central nervous system, thus disrupting communication between the brain and
spinal cord. A radiotracer called [F-18] PBR06 can detect changes in brain
matter through positron emission tomography (PET). [F-18]PBR06 has the
potential to detect the disease before patients show any symptoms giving
doctors the ability to treat the condition.
MS progression’s
identity procedures
·
Some patients may show signs of the disorder,
though in most cases, the doctors will suspect the presence of the disease and
order for tests. [F-18] PBR06 is used to image the patient and give insights
into neurodegeneration and inflammations. MS progression will interfere with
the signal connecting white matter of the brain. The disability is caused by
differences in grey matter, specifically through activation of microglia.
Microglia is the central nervous system's immune cells.
·
The radiotracer uncovers evidence of
inflammation in the white matter of the brain, which progresses to the grey
matter. In phase two of the research, [F-18] PBR06 is introduced. It measures
the activation of microglia in the grey matter of MS patients using PET
imaging. PET measures tissues' metabolism using radioactive
materials, unique cameras, and a computer to
evaluate body organs and tissues' functionality.
·
[F-18]PBR06 targets 18-kDa-translocator protein
(TSPO) found in microglia and macrophages to mark inflammation. This shows high
image quality, better discrimination of real signals for better detection.
Studies show that activation of microglia in grey matter is high in MS patients
brains than those of healthy people.
The brain controls various body processes which are
affected by MS progressions such as emotion, cognition, and memory. Individuals
with secondary progressive MS (SPMS) have high microglial activation in the
thalamus that relapsing-remitting MS (RRMS) patients. They also have healthy
controls. Since microglial activation is like a physical disability, the use of
technology is effective in detecting and developing techniques for treatment.
Comments
Post a Comment